Analysis of TCGA database by applying UALCAN, we examined GALNT1 expression in relation to several clinicopathological parameters in patients with GC, including tumor grade (grade 1, 2, 3), tumor stage (stages I, II, III, and IV), and lymph node stage (N0 1, 2, and 3). The gene discussed is GALNT1; the disease is neoplasm.